VAM
SGNT

Visium Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Visium Asset Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-540,000
Closed -$11.3M – 918
2013
Q2 		$11.3M Buy
+540,000
New +$9.65M 0.26% 68

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Visium Asset Management's SGNT Position: Q3 2013 in Review

Visium Asset Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2013, closing a stake of 540,000 shares — an estimated $11.3M sold.

Visium Asset Management first reported a position in SGNT in Q2 2013 and held it in 1 quarter. The position peaked at $11.3M in Q2 2013. 103 funds tracked by Wall St. Rank hold SGNT as of Q3 2013.

  • Visium Asset Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • Visium Asset Management sold 540,000 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2013, an estimated $11.3M.
  • Visium Asset Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • Visium Asset Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $11.3M in Q2 2013.
  • 103 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2013.

Based on Visium Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.